Blue-Light Filtering Spectacle Lenses: Optical and Clinical Performances

Abstract

PurposesTo evaluate the optical performance of blue-light filtering spectacle lenses and investigate whether a reduction in blue light transmission affects visual performance and sleep quality.MethodsExperiment 1: The relative changes in phototoxicity, scotopic sensitivity, and melatonin suppression of five blue-light filtering plano spectacle lenses were calculated based on their spectral transmittances measured by a spectrophotometer. Experiment 2: A pseudo-randomized controlled study was conducted to evaluate the clinical performance of two blue-light filtering spectacle lenses (BF: blue-filtering anti-reflection coating; BT: brown-tinted) with a regular clear lens (AR) serving as a control. A total of eighty computer users were recruited from two age cohorts (young adults: 18–30 yrs, middle-aged adults: 40–55 yrs). Contrast sensitivity under standard and glare conditions, and colour discrimination were measured using standard clinical tests. After one month of lens wear, subjective ratings of lens performance were collected by questionnaire.ResultsAll tested blue-light filtering spectacle lenses theoretically reduced the calculated phototoxicity by 10.6% to 23.6%. Although use of the blue-light filters also decreased scotopic sensitivity by 2.4% to 9.6%, and melatonin suppression by 5.8% to 15.0%, over 70% of the participants could not detect these optical changes. Our clinical tests revealed no significant decrease in contrast sensitivity either with (95% confidence intervals [CI]: AR–BT [–0.05, 0.05]; AR–BF [–0.05, 0.06]; BT–BF [–0.06, 0.06]) or without glare (95% CI: AR–BT [–0.01, 0.03]; AR–BF [–0.01, 0.03]; BT–BF [–0.02, 0.02]) and colour discrimination (95% CI: AR–BT [–9.07, 1.02]; AR–BF [–7.06, 4.46]; BT–BF [–3.12, 8.57]).ConclusionBlue-light filtering spectacle lenses can partially filter high-energy short-wavelength light without substantially degrading visual performance and sleep quality. These lenses may serve as a supplementary option for protecting the retina from potential blue-light hazard.Trial RegistrationClinicalTrials.gov NCT02821403

The effect of blue‐light blocking spectacle lenses on visual performance, macular health and the sleep‐wake cycle: a systematic review of the literature

“…We included three studies in this review . Two of the studies were conducted in the USA and one in Hong Kong.…”

Insights into Australian optometrists’ knowledge and attitude towards prescribing blue light‐blocking ophthalmic devices

“…16 The optical and clinical performance of blue light-blocking spectacle lenses has been relatively understudied compared with blue light-filtering intraocular lenses. 17,18 Leung et al 9 conducted a pseudo-randomised study to investigate if blue light attenuation affected visual performance and sleep quality. The study outcomes, after 1 month of blue light-blocking lens wear, showed no significant difference in contrast testing (with and without glare), colour discrimination, or sleep quality.…”

Clinical impact of nanophotonic blue-light filtering spectacles based on fullerene C60 and polymethyl methacrylate (PMMA)

“…[6] For this reason, many different filters that reduce that part of the visible spectrum have been developed in order to reduce the effect of blue light on the retina. [7] The nanomaterial based on fullerene C60 and PMMA has been used for nanophotonic contact lenses [8] and spectacles. [9] It has been shown to transform diffuse light into harmonised and hyper-polarised light and these light photons have the same symmetry order (electrical and magnetic planes of photons in space and time) as biomolecules, which interact with light.…”